Mirum Pharmaceuticals, Inc. (MIRM) Free Cash Flow
Mirum Pharmaceuticals, Inc. (MIRM) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2019-12-31 | -$39.64M |
| 2020-12-31 | -$89.30M |
| 2021-12-31 | -$132.78M |
| 2022-12-31 | -$120.41M |
| 2023-12-31 | -$91.05M |
| 2024-12-31 | -$10.67M |
| 2025-12-31 | $54.87M |
How MIRM compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| PRGO | Perrigo Company plc | $145.10M |
| AZTA | Azenta Inc. | $38.32M |
| KURA | Kura Oncology Inc. | -$70.70M |
| IDYA | IDEAYA Biosciences Inc. | -$73.47M |
| RGNX | REGENXBIO Inc. | -$126.38M |
These are five companies in the same sector as MIRM with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Mirum Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("MIRM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MIRM | $96.72 | +0.43% | 0.37M |
| 3 | ||||
| 4 | ||||
| 5 |